Advanced search
Publication Cover
Journal of Medical Economics Volume 21, 2018 - Issue 1
Submit an article Journal homepage
740
Views
3
CrossRef citations to date
0
Altmetric
Cardiovascular

The cost-effectiveness and monetary benefits of dabigatran in the prevention of arterial thromboembolism for patients with non-valvular atrial fibrillation in the Netherlands

Marinus van HulstDepartment of Clinical Pharmacy and Toxicology, Martini Hospital, Groningen, The Netherlands; ;Department of PharmacoTherapy, Epidemiology & Economics, Department of Pharmacy, University of Groningen, Groningen, The Netherlands; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-3216-7246
ORCID Icon,
Jelena StevanovicDepartment of PharmacoTherapy, Epidemiology & Economics, Department of Pharmacy, University of Groningen, Groningen, The Netherlands;
,
Maartje S. JacobsDepartment of Clinical Pharmacy and Toxicology, Martini Hospital, Groningen, The Netherlands; ;Department of PharmacoTherapy, Epidemiology & Economics, Department of Pharmacy, University of Groningen, Groningen, The Netherlands; ORCID Iconhttp://orcid.org/0000-0002-6185-4718
ORCID Icon,
Robert G. TielemanDepartment of Cardiology, Martini Hospital, Groningen, The Netherlands; ;Department of Cardiology, University Medical Center Groningen, Groningen, The Netherlands;
,
Bregt KappelhoffBoehringer Ingelheim, Alkmaar, The Netherlands;
&
Maarten J. PostmaDepartment of PharmacoTherapy, Epidemiology & Economics, Department of Pharmacy, University of Groningen, Groningen, The Netherlands; ;Institute of Science in Healthy Aging & healthcaRE (SHARE), University Medical Center Groningen (UMCG), University of Groningen, Groningen, The Netherlands; ;Department of Epidemiology, University Medical Center Groningen, Groningen, The Netherlands
Pages 38-46 | Received 13 Jun 2017, Accepted 23 Aug 2017, Published online: 07 Sep 2017

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.